Squarepoint Ops LLC Avrobio, Inc. Transaction History

Squarepoint Ops LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.15 - $1.48 $44,498 - $57,267	38,694 New	38,694 $49,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $103,192 - $180,961	-29,911 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $47,867 - $80,327	8,656 Added 40.72%	29,911 $167,000
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $544,817 - $875,599	-69,492 Reduced 76.58%	21,255 $189,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $642,117 - $1.18 Million	60,922 Added 204.26%	90,747 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $222,648 - $297,676	-17,408 Reduced 36.86%	29,825 $416,000
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $349,989 - $522,963	-26,943 Reduced 36.32%	47,233 $615,000
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $604,270 - $1.14 Million	49,571 Added 201.47%	74,176 $1.29 Million
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $257,947 - $696,303	-25,590 Reduced 50.98%	24,605 $383,000
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $282,584 - $473,789	21,654 Added 75.87%	50,195 $1.01 Million
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $402,998 - $669,001	28,541 New	28,541 $403,000
Q1 2019 May 15, 2019	SELL	$12.46 - $22.05 $135,440 - $239,683	-10,870 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$15.43 - $32.7 $167,724 - $355,449	10,870 New	10,870 $181,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.